Biomarkers

Homocysteine

An amino acid byproduct that signals B-vitamin status and vascular risk

Plain English

Homocysteine is a sulfur-containing amino acid produced as a natural byproduct of protein metabolism. Under normal conditions, it is quickly recycled back into useful compounds with help from B vitamins. When B-vitamin status is inadequate or genetic factors slow this recycling, homocysteine accumulates in the blood and damages arterial walls, raising risk for cardiovascular disease, cognitive decline, and stroke.

The Mechanism

Homocysteine forms from methionine, an essential amino acid abundant in meat and eggs. After methionine is used in cellular processes, it leaves behind homocysteine as a metabolic intermediate. Two recycling pathways clear it: remethylation (which converts it back to methionine using folate, B12, and the MTHFR enzyme) and transsulfuration (which converts it to cysteine using B6 and B2).

When these pathways are impaired, whether by low B-vitamin intake, genetic variants in the MTHFR gene, kidney dysfunction, or high protein intake without adequate micronutrient support, homocysteine accumulates. Elevated homocysteine damages the endothelium (the inner lining of blood vessels) through oxidative stress and promotes platelet aggregation, both of which accelerate atherosclerosis and increase clot risk.

The brain is particularly vulnerable. The VITACOG trial (Smith et al., 2010, Oxford) found that B-vitamin supplementation in people with mild cognitive impairment significantly slowed brain atrophy in those with elevated baseline homocysteine, suggesting that homocysteine elevation is a modifiable contributor to accelerated brain aging. Levels above 15 micromol/L are associated with roughly double the risk of Alzheimer's disease.

Why It Matters

Elevated homocysteine is often a B-vitamin deficiency in disguise, and it is fixable in weeks.

Homocysteine is an underused biomarker that sits at the intersection of cardiovascular and cognitive risk. Because it responds directly to B-vitamin status, it is highly modifiable: bringing levels from 12 down to 8 micromol/L with B12, folate, and B6 supplementation is achievable within weeks for most people. Unlike statins for cardiovascular risk, the intervention is cheap, low-risk, and doubles as cognitive protection.

Common Misconception

Most people associate homocysteine only with heart disease and assume it is only relevant after a cardiac event. In practice, it is one of the clearest early-warning signals for cognitive aging: the evidence for homocysteine and brain atrophy rate is stronger than the evidence for most other modifiable cognitive risk factors. It is also not a dietary fat or cholesterol issue, so standard lipid-focused advice misses it entirely.

What a Healthy Range Looks Like

Elevated

>15 µmol/L

Hyperhomocysteinemia: significantly elevated cardiovascular and cognitive risk

Borderline

10-15 µmol/L

Above optimal; B-vitamin optimization is indicated

Acceptable

7-10 µmol/L

Within normal clinical range; lower end is preferable

Optimal

<7 µmol/L

Associated with lowest cardiovascular and cognitive risk in population data

Most labs flag homocysteine above 15 micromol/L as high; many researchers now consider anything above 10 as suboptimal. The functional target for cardiovascular and cognitive protection is below 7-8 micromol/L. Response to B-vitamin supplementation is rapid: most people see meaningful reductions within 4-8 weeks.

Signs It Is Disrupted

No specific symptoms at mildly elevated levels; it is a silent risk factor like high blood pressure
Tingling or numbness in extremities can indicate concurrent B12 deficiency driving homocysteine elevation
Fatigue and brain fog that do not resolve with adequate sleep may reflect underlying B12 or folate insufficiency
History of early cardiovascular disease, stroke, or blood clots in first-degree relatives
Known MTHFR genetic variant (especially compound heterozygous or homozygous C677T) without B-vitamin optimization

How to Improve It

→

Folate (B9). 400-800 mcg of methylfolate daily (the bioactive form, especially important for MTHFR variants) is the most potent single nutrient for lowering homocysteine, reducing levels by 25% on average in studies by Wald et al. (2001).

→

Vitamin B12. 500-1,000 mcg of methylcobalamin (not cyanocobalamin) daily addresses B12 deficiency, which is extremely common in people over 50 and in those following plant-based diets.

→

Vitamin B6. 10-25 mg of B6 (pyridoxine) daily supports the transsulfuration pathway; works synergistically with folate and B12, as the Homocysteine Lowering Trialists Collaboration (2002) showed that combining all three is more effective than any alone.

→

Increase whole food protein variety. Ensuring adequate B-vitamin intake from leafy greens, legumes, eggs, and fortified foods supports both remethylation pathways without requiring high-dose supplements.

→

Reduce alcohol. Chronic alcohol intake impairs B-vitamin absorption and depletes folate, both of which elevate homocysteine; even moderate drinking can elevate levels in B-vitamin-marginal individuals.

3 Things to Remember

Homocysteine is a metabolic byproduct that accumulates when B-vitamin status (folate, B12, B6) is inadequate; it directly damages arterial walls and accelerates brain atrophy.

Levels above 10 micromol/L are worth addressing; levels above 15 are associated with double the Alzheimer's risk and significantly elevated cardiovascular risk.

B12, methylfolate, and B6 supplementation typically reduces homocysteine by 25-30% within 4-8 weeks, making it one of the most modifiable risk biomarkers in standard labs.

Appears In

→The Lab Work & Biomarkers Protocol →The Stress & Cortisol Protocol

Protocol

Turn what you've learned into daily practice

Protocol pulls your wearable and nutrition data together into a daily health score, morning brief, and AI coaching. All in one place.

Get started free